TipRanks
Ionis Pharmaceuticals (DE:ISI)
XETRA:ISI
Germany Market
ISI
Ionis Pharmaceuticals
RESEARCH TOOLSreports

Ionis Pharmaceuticals (ISI) Stock News & Sentiment

5 Followers
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
Premium
Market News
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
7d ago
AZN
MRK
Ionis Advances CHAMPION Phase 3 Trial in Angelman Syndrome, Raising Long‑Term Optionality for IONS Investors
Premium
Company Announcements
Ionis Advances CHAMPION Phase 3 Trial in Angelman Syndrome, Raising Long‑Term Optionality for IONS Investors
16d ago
IONS
Stringer Reiterates Buy on Ionis as Late-Stage Pipeline Delivers; Price Target Maintained at $86
Premium
Ratings
Stringer Reiterates Buy on Ionis as Late-Stage Pipeline Delivers; Price Target Maintained at $86
21d ago
IONS
Ionis and Roche Report Positive Phase 3 IgAN Data
Premium
Company Announcements
Ionis and Roche Report Positive Phase 3 IgAN Data
21d ago
8K
IONS
Ionis: Strong ALS Data and Underappreciated Pipeline Support Buy Rating and Unchanged $100 Price Target
Premium
Ratings
Ionis: Strong ALS Data and Underappreciated Pipeline Support Buy Rating and Unchanged $100 Price Target
21d ago
IONS
Ionis Stock Sinks 10% as Analysts Cut Targets After Pelacarsen Trial Miss
Premium
Market News
Ionis Stock Sinks 10% as Analysts Cut Targets After Pelacarsen Trial Miss
1M ago
AZN
NVS
Novartis Stock (NVS) Sinks on Another Setback, Muscle-Wasting Disorder Drug Disappoints
Premium
Market News
Novartis Stock (NVS) Sinks on Another Setback, Muscle-Wasting Disorder Drug Disappoints
1M ago
NVS
IONS
More DE:ISI News >

ISI News on the Web

Alnylam vs. Ionis: Here's the Better Bad-News Buy
The Motley Fool
Neutral
Ionis Pharmaceuticals (IONS) Receives a Buy from Bank of America Securities
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Immunovant (IMVT) and Ionis Pharmaceuticals (IONS)
TipRanks News
Bullish
Ionis: Strong ALS Data and Underappreciated Pipeline Support Buy Rating and Unchanged $100 Price Target
TipRanks News
Bullish
Ionis Pharmaceuticals price target lowered to $70 from $76 at JPMorgan
TipRanks News
Bullish
Investors Dumped Ionis Pharmaceuticals Stock -- But Wall Street Hasn't Budged From Its Bullish Outlook
The Motley Fool
Bullish
Ionis Has Its First Neurology Launch, But Can Zanvastro Justify Its $285,000 Price?
Insider Monkey
Neutral

News Score - Last 7 Days

Very Positive
DE:ISI
Sector Average
Media Buzz
This Week5 articles
Weekly Average9 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ISI’s Media Buzz Sentiment?
5 articles about DE:ISI were published this week. In an average week, 9 articles are published.
    What is DE:ISI’s weekly average amount of articles?
    In an average week, 9 articles about DE:ISI are published.
      What is DE:ISI’s News Sentiment?
      100% of articles about DE:ISI were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        RYTMRhythm Pharmaceuticals
        DHRDanaher
        HALOHalozyme
        VRTXVertex Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week